207_Combined course Presentations

Positive prognostic role of MGMT methylation

• Median OS: 18.2 vs 12.2 months

 Overall, MGMT promoter

methylated in 45% of patients

 MGMT promoter was an independent favorable prognostic factor, irrespective of treatment.

Hegi M. et al. NEJM 2005;352